AMENDED AND RESTATED EXECUTIVE RETENTION AGREEMENTExecutive Retention Agreement • February 26th, 2021 • Moderna, Inc. • Biological products, (no disgnostic substances) • Massachusetts
Contract Type FiledFebruary 26th, 2021 Company Industry JurisdictionThis Amended and Restated Executive Retention Agreement (this “Agreement”) is entered into effective as of February 23, 2021 (the “Effective Date”) between Tal Zaks, M.D. (the “Executive”) and Moderna, Inc. (the “Company,” together with Executive, the “Parties”).